COGT icon

Cogent Biosciences
COGT

Overview Fund Activity

135 hedge funds and large institutions have $886M invested in Cogent Biosciences in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
–
Holders Change %
0%
% of All Funds
2.15%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
12
Increased
58
Reduced
36
Closed
12
Calls
$940K
Puts
$275K
Net Calls
+$665K
Net Calls Change
+$444K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$44.6M
2
SCM
2
Suvretta Capital Management
New York
$29.8M
3
BlackRock
3
BlackRock
New York
$59.9M
4
SVCM
4
Saturn V Capital Management
Texas
$17.3M
5
KCM
5
Kynam Capital Management
New Jersey
$21.5M

Top Sellers

1
DM
1
Deerfield Management
New York
$10.6M
2
EAM
2
Eventide Asset Management
Massachusetts
$21M
3
LGM
3
Logos Global Management
California
$0
4
FCM
4
Farallon Capital Management
California
$166K
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$36.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
CAM
26
Cormorant Asset Management
Massachusetts
$9.75M – – –
5VM
27
5AM Venture Management
California
$7.71M – – –
CS
28
Candriam SCA
Luxembourg
$7.53M +$48.4K +5,000 +0.6%
Northern Trust
29
Northern Trust
Illinois
$6.95M +$961K +98,532 +16%
SCM
30
Silverarc Capital Management
Massachusetts
$6.35M +$306K +31,372 +5%
GTC
31
Ghost Tree Capital
New York
$6.34M +$731K +75,000 +13%
Assenagon Asset Management
32
Assenagon Asset Management
Luxembourg
$5.94M -$871K -89,373 -13%
Charles Schwab
33
Charles Schwab
California
$5.78M +$3.88M +397,765 +204%
NCM
34
Nantahala Capital Management
Connecticut
$5.61M +$4.98M +510,868 +797%
Walleye Capital
35
Walleye Capital
New York
$5.39M -$432K -44,318 -7%
BC
36
Boxer Capital
California
$5.12M – – –
NLVP
37
New Leaf Venture Partners
New York
$4.89M – – –
PIM
38
Platinum Investment Management
Australia
$4.64M -$12.1K -1,243 -0.3%
SFM
39
Sphera Funds Management
Israel
$4.1M – – –
Goldman Sachs
40
Goldman Sachs
New York
$3.9M +$342K +35,048 +10%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$2.81M +$385K +39,491 +16%
JPMorgan Chase & Co
42
JPMorgan Chase & Co
New York
$2.62M +$19K +1,953 +0.7%
KCM
43
Kennedy Capital Management
Missouri
$2.6M -$5.1K -523 -0.2%
SSA
44
Schonfeld Strategic Advisors
New York
$2.32M +$388K +39,805 +20%
ACM
45
Altium Capital Management
New York
$2.29M – – –
Macquarie Group
46
Macquarie Group
Australia
$2.24M – – –
Connor, Clark & Lunn Investment Management (CC&L)
47
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.2M -$489K -50,194 -18%
PBA
48
Paradigm Biocapital Advisors
New York
$2.2M +$2.2M +225,605 New
Nuveen Asset Management
49
Nuveen Asset Management
Illinois
$2.16M -$317K -32,551 -13%
HS
50
HighVista Strategies
Massachusetts
$1.94M -$171K -17,543 -8%
1
2
3 4 5